Home
Conditions
Lung Diseases, Interstitial

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 133 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study

NCT04665674

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis Pulmonary, +5 more
Locations: French national reference centre for Histiocytoses Paris, France

View Trial Details

Recruiting

Korean Idiopathic Pulmonary Fibrosis Registry

NCT04160715

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Seoul National University Bundang Hospital Seongnam-si, South Korea

View Trial Details

Recruiting

Controls for Respiratory Diseases

NCT03120481

Conditions: Actinomycetales Infections, Asthma, Bacterial Infections, +30 more
Locations: Seoul National University Healthcare System Gangnam Center Seoul, South Korea

View Trial Details

Enrolling by Invitation

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

NCT06169397

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations: Xentria Investigative Site Denver, Colorado, United States

Xentria Investigative Site Chicago, Illinois, United States

Xentria Investigative Site Greenville, North Carolina, United States

Xentria Investigative Site Cincinnati, Ohio, United States

View Trial Details

Enrolling by Invitation

Telomeres Length in Israeli Fibrotic ILD Patients

NCT06885515

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Barzilai Medical Center Ashkelon, Israel

Tel Aviv Medical Center Tel Aviv, Israel

View Trial Details

Enrolling by Invitation

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT06751602

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +5 more
Locations: Houston Methodist Research Institute Houston, Texas, United States

View Trial Details

Enrolling by Invitation

Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context

NCT07061873

Conditions: Fibrosis, Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease in Patients With Rheumatoid Arthritis, +6 more
Locations: Universidad de La Frontera Temuco, Cautín, Chile

View Trial Details

Enrolling by Invitation

Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents

NCT06902792

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Second Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT05285878

Conditions: Behavior, Chronic Disease, Disease Attributes, +24 more
Locations: Houston Methodist Research Institute Houston, Texas, United States

View Trial Details

Enrolling by Invitation

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

NCT03755245

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +22 more
Locations: Turku University Hospital, Turku PET Centre Turku, Finland

View Trial Details

Lung Diseases, Interstitial

Lung Diseases, Interstitial trial results

Related conditions